Claudin-2 Protects from Colitis-Associated Cancer by Promoting Colitis-Associated Mucosal Healing

Investigators demonstrated a novel role of claudin-2 in promoting mucosal healing in inflammatory bowel disease patients and thus regulating vulnerability to colitis severity and colitis-associated cancer, which can be exploited for improved clinical management.